Disc Medicine (IRON): Director sold ~$41K

~$41K

Approx. value · 664 sh @ $61.13

677K

Holds after · shares reported

Traded

Jul 18, 2025

Filed

Jul 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 20, 2025InsiderOfficer sold ~$334K of IRON shares in the open market
2. Jun 6, 2025InsiderOfficer sold ~$150K of IRON shares in the open market
3. Jun 16, 2025InsiderCFO sold ~$105K of IRON shares in the open market
4. Jul 3, 2025InsiderCEO sold ~$286K of IRON shares in the open market
5. Jul 9, 2025Insider · 1 personInsiders: 2 sales (~$1.9M)
6. Jul 10, 2025InsiderCFO sold ~$115K of IRON shares in the open market
7. Jul 17, 2025InsiderCFO sold ~$120K of IRON shares in the open market
8. Jul 18, 2025 · this disclosureInsiderDirector sold ~$41K of IRON shares in the open market

What came next

1. Jul 23, 2025InsiderDirector sold ~$1.82M of IRON shares in the open market
2. Jul 24, 2025InsiderDirector sold ~$797K of IRON shares in the open market
3. Jul 30, 2025InsiderDirector sold ~$518K of IRON shares in the open market
4. Aug 5, 2025InsiderDirector sold ~$24K of IRON shares in the open market
5. Aug 13, 2025InsiderDirector sold ~$1.53M of IRON shares in the open market
6. Aug 14, 2025InsiderDirector sold ~$440K of IRON shares in the open market
7. Aug 22, 2025InsiderDirector sold ~$140K of IRON shares in the open market
8. Oct 3, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 3, 2025, Mona Ashiya, Ph.D., a Class I member of the Board of Directors (the “Board”) of Disc Medicine, Inc. (the “Company”), notified the Company of her resignation from the Board, effective October 3, 2025.”
9. Oct 20, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
10. Oct 20, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
11. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Disc Medicine

For Disc Medicine, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IRON page.

Other recent filings by Kevin Bitterman, Director

• SEC Form 4 at Disc Medicine (IRON)Oct 21, 2026
• SEC Form 4 at Disc Medicine (IRON)Oct 21, 2026
• SEC Form 4 at Disc Medicine (IRON)Oct 21, 2026
• SEC Form 4 at Disc Medicine (IRON)Oct 21, 2026
• SEC Form 4 at Disc Medicine (IRON)Oct 21, 2026

The full history of Kevin Bitterman, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Disc Medicine

• SEC Form 4Nov 12, 2026
• SEC Form 144Nov 10, 2026
• SEC Schedule 13DOct 26, 2026
• SEC Form 144Oct 21, 2026
• SEC Form 144Oct 21, 2026
• SEC Form 144Oct 21, 2026

Everything OQRO holds on this company is on its IRON page.